2-Amino-1-(4-chloro-phenyl)-ethanone; hydrochloride, 95.0%, 5g

2-Hydrazino-4,7-dimethyl-1,3-benzothiazole, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 0.50 µm, 1 Piece(s)

(2R,3R,4S,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol, 98%, 250mg

trans-4'-Cyano-[1,1'-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate, 97%, 25g

1,3-Diisopropenylbenzene (stabilized with TBC)>97.0%(GC)25mL

1-Methoxycyclobutane-1-carboxylic acid, >95%, 5g

(2-Fluoro-5-isopropoxypyridin-3-yl)methanol, 98%, 1g

1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]ethan-1-one, 97%, 2.5g

2-(Cyclopentylmethyl)butanoic acid, 95%, 100mg

Methyl 3-amino-5-bromobenzoate, 95.0%, 100g

4-bromo-2-{[(butan-2-yl)amino]methyl}phenol hydrochloride, 95.0%, 2g

2-Bromo-4-(hydroxymethyl)benzonitrile, 98%, 5g